Upper Urinary Tract Surgery with Hugo TM RAS: A Systematic Review.
Andrea Noya-Mourullo, Pietro Pasquini, Sara Tamburini et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review assessed the feasibility and safety of the Hugo™ RAS multicart robotic platform for upper urinary tract surgery. Nineteen studies involving 226 patients were included; most evaluated robot-assisted partial nephrectomy, with other procedures represented by small numbers of studies or cases. Robotic configurations varied, with three arms used in 36.8% of studies and four arms in 52.6%. Across the reviewed procedures, mean operative time was 93 ± 41 minutes, estimated blood loss was 150 ± 86.15 mL, and mean hospital stay was 3 ± 2 days. The authors concluded that the platform appears effective and adaptable.
Key findings
- Nineteen studies comprising 226 patients were analyzed; 14 studies evaluated robot-assisted partial nephrectomy.
- Three robotic arms were used in 36.8% of studies, while four arms were used in 52.6%.
- Mean operative time was 93 ± 41 minutes, estimated blood loss 150 ± 86.15 mL, and hospital stay 3 ± 2 days.
Why it matters
The review summarizes early clinical experience with a robotic platform across varied upper urinary tract procedures and configurations. Its findings offer clinicians an overview of reported operative metrics and the range of procedures performed, while the small, heterogeneous evidence base means these results are best interpreted as descriptive rather than as comparative evidence of performance.
What to keep in mind
The evidence comprised only 19 heterogeneous studies and 226 patients, with most studies focused on partial nephrectomy and limited representation of other procedures.